Go Pro
NASDAQ:YI

111 Q2 2026 Earnings Report

111 logo
$3.54 +0.16 (+4.73%)
Closing price 09/17/2026 04:00 PM Eastern
Extended Trading
$3.54 +0.00 (+0.14%)
As of 04:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

111 EPS Results

Actual EPS
-$0.59
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

111 Revenue Results

Actual Revenue
$338.55 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

111 Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Thursday, September 17, 2026
Conference Call Time
9:30AM ET

Upcoming Earnings

111's Q3 2026 earnings is estimated for Thursday, November 26, 2026, based on past reporting schedules

Earnings Documents

111 Earnings Headlines

111, Inc Q2 Loss Widens From Lower Revenue; Shares Up
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel
See More 111 Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 111? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 111 and other key companies, straight to your email.

About 111

111 (NASDAQ:YI), Inc. is a China-based digital healthcare company that operates an online platform connecting consumers, pharmacies, hospitals, pharmaceutical manufacturers and other healthcare participants. The company focuses on improving access to medicines and healthcare products through technology-enabled distribution and retail services.

Its business includes online sales and distribution of prescription and over-the-counter medicines, medical devices, nutritional products and other healthcare merchandise. 111 also provides business-to-business services that help pharmacies and medical institutions source products, manage inventory and access digital tools, while its consumer-facing operations offer online medicine and healthcare product purchasing.

Founded in 2010 and headquartered in Shanghai, 111 primarily serves the Chinese market. The company was established by Junling Liu, who has served as its chief executive officer and chairman. Its American depositary shares trade on the Nasdaq Global Market under the symbol YI.

View 111 Profile